Blog Archive
-
▼
2008
(66)
-
▼
January
(6)
- NicOx, extension of ophthalmology agreement with P...
- Transgene's Therapeutic Vaccine TG4010, Phase IIb ...
- Iris Pharma and Clirophtha merger, unique ophthalm...
- BT PHARMA, development of therapeutic cancer vacci...
- Aureus Pharma's AurSCOPE Ion Channel licenses to ...
- Merck Serono and Flamel to Collaborate on an Exten...
-
▼
January
(6)
Saturday, January 12, 2008
Aureus Pharma's AurSCOPE Ion Channel licenses to Neuromed Pharmaceuticals
Paris, FRANCE, December 11, 2007 - Aureus Pharma a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces that Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved chronic pain drugs has licensed the AurSCOPE Ion Channel Knowledge database... Aureus ' Press Release-